Axonis Therapeutics, Inc.
Biotechnology company · Boston, Massachusetts, United States
Axonis Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $3.8 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $46 million sold in a notice filed in 2024.
Axonis Therapeutics at a glance
What does Axonis Therapeutics do?
US government research funding
6 SBIR/STTR small-business research awards from US health agencies, $3.8 million in total (2020 to 2024). NIH funding came from the National Institute of Neurological Disorders and Stroke, National Eye Institute, National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $46 million sold (2024).
Frequently asked questions about Axonis Therapeutics
Where is Axonis Therapeutics headquartered?
Axonis Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.
What does Axonis Therapeutics do?
Axonis Therapeutics, Inc. is a biotechnology company.
Similar companies
- Syntis Bio, Inc.Boston, Massachusetts, United States
- Strand Therapeutics Inc.Boston, Massachusetts, United States
- Pear Therapeutics, Inc.Boston, Massachusetts, United States
- Aura Biosciences, Inc.Boston, Massachusetts, United States
- Holobiome, Inc.Boston, Massachusetts, United States
- Leuko Labs, Inc.Boston, Massachusetts, United States
- Compass Therapeutics, Inc.Boston, Massachusetts, United States
- Odyssey Therapeutics, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences